Search
Now showing items 1-1 of 1
Evaluation Of Response To Imatinib Mesylate Therapy Among Chronic Myeloid Leukaemia Patients As Seen In Nairobi, Kenya
(University of Nairobi, 2018)
Background: Without treatment, chronic myeloid leukemia (CML) progresses from a
chronic phase (CP) followed by an accelerated phase (AP) and then to the blast phase
(BP).The approval of imatinib mesylate by the Food and ...